Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-03-13 | 2019-01-28 |
| Drug Identification Number | 02239092 | 02239092 |
| Brand name | ATACAND TAB 16 MG | ATACAND TAB 16 MG |
| Common or Proper name | candesartan cilexetil tablets | candesartan cilexetil tablets |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Ingredients | CANDESARTAN CILEXETIL | CANDESARTAN CILEXETIL |
| Strength(s) | 16MG | 16MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 2 x 15 tablet blisters | 1 x 15 tablet blisters |
| ATC code | C09CA | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2019-02-09 | 2019-02-09 |
| Actual start date | ||
| Estimated end date | 2019-04-01 | 2019-02-11 |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fulfilling additional Health Canada requirements | Fulfilling additional Health Canada requirements |
| Health Canada comments |